THE SINGLE BEST STRATEGY TO USE FOR MBL77

Not all clients with CLL need therapy. Despite all current innovations, the iwCLL even now suggests watchful observation for patients with asymptomatic disease.86 This advice relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trials